{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-017464","form_type":"8-K","ticker":"HSDT","cik":"0001610853","company_name":"Solana Co","filed_at":"2023-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.773976+00:00","generated_at":"2026-06-09T00:26:56.540476+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Helius Medical pre-announces Q3 revenue $140-150K; cash runway into Q2 2024","bullets":["Expects Q3 revenue $140-150K, down after PTAP ended June 30, 2023.","Cash, equivalents and warrant proceeds ~$7.0M, extending runway into Q2 2024.","Cash used in ops Q3: $2.4-2.5M; first nine months: $8.3-8.4M, reflecting cost management.","Full Q3 results to be released Nov 9, 2023 after market close."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-017464","json":"https://secwatch.observer/filing/0001558370-23-017464.json","markdown":"https://secwatch.observer/filing/0001558370-23-017464.md","text":"https://secwatch.observer/filing/0001558370-23-017464.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1610853/000155837023017464/0001558370-23-017464-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1610853/000155837023017464/hsdt-20231102x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T00:26:56.540476+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1ee9562eb15025656bfde74ef11781f017f18bbe","claim":"Solana Co reported the quarter ended September 30, 2023 results: revenue $140 - $150 thousand. Guidance initiated.","evidence_excerpt":"Expects to report Q3 revenues in range of $140 - $150 thousand, reflecting the expected decrease in U.S. sales with the conclusion of the Patient Therapy Access Program (PTAP) on June 30, 2023","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1610853/000155837023017464/0001558370-23-017464-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2023"},{"label":"Revenue","value":"$140 - $150 thousand"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}